Anspor

Active Ingredient(s): Cephradine
FDA Approved: * October 1, 1974
Pharm Company: * GLAXOSMITHKLINE
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Anspor Overview

Cefradine (INN) or cephradine (BAN) is a first generation cephalosporin antibiotic.[1] Contents 1 Indications 2 Formulations 3 Synthesis 4 Production names 5 See also 6 Notes 7 References Indications Respiratory tract infections (such as tonsillitis, pharyngitis, and lobar pneumonia) caused by group A beta-hemolytic streptococci and S. pneumoniae (formerly D. pneumonia).[note 1] Otitis media caused by group A beta-hemolytic streptococci, S. pneumoniae...

Read more Anspor Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cefradine

Recent Anspor Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cephradine
  • Capsule: 250mg, 500mg
  • For Suspension: 125mg/5ml, 250mg/5ml
  • Powder for Reconstitution: 250mg/5ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Cephradine or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 July 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA